259 related articles for article (PubMed ID: 23980564)
1. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
[TBL] [Abstract][Full Text] [Related]
2. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
[TBL] [Abstract][Full Text] [Related]
3. Macro CK2 accumulation in tenofovir-treated HIV patients is facilitated by CK oligomer stabilization but is not predictive for pathology.
Schmid H; Tokarska-Schlattner M; Füeßl B; Röder M; Kay L; Attia S; Lederer SR; Goebel FD; Schlattner U; Bogner JR
Antivir Ther; 2013; 18(2):193-204. PubMed ID: 22894916
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction.
Morelle J; Labriola L; Lambert M; Cosyns JP; Jouret F; Jadoul M
Clin Nephrol; 2009 May; 71(5):567-70. PubMed ID: 19473619
[TBL] [Abstract][Full Text] [Related]
5. An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database).
Danjuma MI; Mohamad-Fadzillah NH; Khoo S
Int J STD AIDS; 2014 Mar; 25(4):273-9. PubMed ID: 24067251
[TBL] [Abstract][Full Text] [Related]
6. Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice.
Day SL; Leake Date HA; Bannister A; Hankins M; Fisher M
J Acquir Immune Defic Syndr; 2005 Mar; 38(3):301-4. PubMed ID: 15735448
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration.
Ezinga M; Wetzels JF; Bosch ME; van der Ven AJ; Burger DM
Antivir Ther; 2014; 19(8):765-71. PubMed ID: 24584104
[TBL] [Abstract][Full Text] [Related]
8. Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.
Judd A; Boyd KL; Stöhr W; Dunn D; Butler K; Lyall H; Sharland M; Shingadia D; Riordan A; Gibb DM
AIDS; 2010 Feb; 24(4):525-34. PubMed ID: 20139752
[TBL] [Abstract][Full Text] [Related]
9. Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.
Gatanaga H; Tachikawa N; Kikuchi Y; Teruya K; Genka I; Honda M; Tanuma J; Yazaki H; Ueda A; Kimura S; Oka S
AIDS Res Hum Retroviruses; 2006 Aug; 22(8):744-8. PubMed ID: 16910829
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.
Buchacz K; Brooks JT; Tong T; Moorman AC; Baker RK; Holmberg SD; Greenberg A;
HIV Med; 2006 Oct; 7(7):451-6. PubMed ID: 16925731
[TBL] [Abstract][Full Text] [Related]
11. Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate.
Pradat P; Le Pogam MA; Okon JB; Trolliet P; Miailhes P; Brochier C; Maynard M; Bailly F; Zoulim F; Cotte L
J Viral Hepat; 2013 Sep; 20(9):650-7. PubMed ID: 23910650
[TBL] [Abstract][Full Text] [Related]
12. Discontinuation of tenofovir disoproxil fumarate for presumed renal adverse events in treatment-naïve HIV-1 patients: meta-analysis of randomized clinical studies.
Winston J; Chonchol M; Gallant J; Durr J; Canada RB; Liu H; Martin P; Patel K; Hindman J; Piontkowsky D
HIV Clin Trials; 2014; 15(6):231-45. PubMed ID: 25433663
[TBL] [Abstract][Full Text] [Related]
13. Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients.
Gupta SK; Anderson AM; Ebrahimi R; Fralich T; Graham H; Scharen-Guivel V; Flaherty JF; Fortin C; Kalayjian RC; Rachlis A; Wyatt CM
PLoS One; 2014; 9(3):e92717. PubMed ID: 24651857
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection.
Gracey DM; Snelling P; McKenzie P; Strasser SI
Antivir Ther; 2013; 18(7):945-8. PubMed ID: 23839869
[TBL] [Abstract][Full Text] [Related]
15. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
[TBL] [Abstract][Full Text] [Related]
16. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.
Labarga P; Barreiro P; Martin-Carbonero L; Rodriguez-Novoa S; Solera C; Medrano J; Rivas P; Albalater M; Blanco F; Moreno V; Vispo E; Soriano V
AIDS; 2009 Mar; 23(6):689-96. PubMed ID: 19262355
[TBL] [Abstract][Full Text] [Related]
17. Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
Nishijima T; Kawasaki Y; Tanaka N; Mizushima D; Aoki T; Watanabe K; Kinai E; Honda H; Yazaki H; Tanuma J; Tsukada K; Teruya K; Kikuchi Y; Gatanaga H; Oka S
AIDS; 2014 Aug; 28(13):1903-10. PubMed ID: 25259702
[TBL] [Abstract][Full Text] [Related]
18. Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation.
Uglietti A; Zanaboni D; Gnarini M; Maserati R
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1305-14. PubMed ID: 22943210
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of tenofovir treatment.
Rodriguez-Novoa S; Labarga P; Soriano V
Pharmacogenomics; 2009 Oct; 10(10):1675-85. PubMed ID: 19842939
[TBL] [Abstract][Full Text] [Related]
20. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
